Axsome Therapeutics Inc
AXSM·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$168.98
Today
+0.4%
YTD
-7.0%
About
Axsome Therapeutics is a New York-based pharmaceutical company founded in 2012. The firm focuses on developing and expanding treatment options for patients across the US who live with central nervous system disorders. Axsome trades under the ticker AXSM on the NASDAQ CM. Add this stock to your watchlist today to monitor AXSM price changes.
Price chart
Closing price history for AXSM (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-47.10
P/S (TTM)11.81
P/B (TTM)111.17
Market cap$9.28B
Cap tierMid-cap
Industry avg P/E-2.18
Profitability
Gross margin91.96%
EBIT margin-23.55%
Net margin-23.50%
ROE-245.10%
ROA-27.35%
Earnings & Revenue
Revenue (TTM)$776.57M
Revenue growth (1Y)+56.9%
EPS (TTM)-$3.76
Free cash flow$-71.96M
Total debt$224.69M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.75
Employees925
Next earnings2 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.